DAVITA INC. Proceeds from Sale of Available-for-sale Securities, Equity
DAVITA INC. (DVA) reported Proceeds from Sale of Available-for-sale Securities, Equity of $6.41 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-23.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity · last filed 2018-02-23
- DAVITA INC. proceeds from sale of available-for-sale securities, equity for the quarter ending 2016-12-31 was $10.33M.
- DAVITA INC. proceeds from sale of available-for-sale securities, equity for the quarter ending 2016-09-30 was $3.30M, a 109.26% increase year-over-year.
- DAVITA INC. proceeds from sale of available-for-sale securities, equity for the quarter ending 2016-06-30 was $285.00K.
- DAVITA INC. proceeds from sale of available-for-sale securities, equity for the quarter ending 2016-03-31 was $1.06M, a 12.74% decline year-over-year.
- DAVITA INC. proceeds from sale of available-for-sale securities, equity for fiscal 2017 was $6.41M, a 57.20% decline from fiscal 2016.
- DAVITA INC. proceeds from sale of available-for-sale securities, equity for fiscal 2016 was $14.97M, a 1056.06% increase from fiscal 2015.
- DAVITA INC. proceeds from sale of available-for-sale securities, equity for fiscal 2015 was $1.29M, a 2.61% increase from fiscal 2014.
- DAVITA INC. proceeds from sale of available-for-sale securities, equity for fiscal 2014 was $1.26M.
| Period end | Proceeds from Sale of Available-for-sale Securities, Equity 3 month | Proceeds from Sale of Available-for-sale Securities, Equity 6 month | Proceeds from Sale of Available-for-sale Securities, Equity 9 month | Proceeds from Sale of Available-for-sale Securities, Equity 9 month as first filed | Proceeds from Sale of Available-for-sale Securities, Equity 12 month |
|---|---|---|---|---|---|
| 2017-12-31 | $6.41M 10-K · filed 2018-02-23 | ||||
| 2016-12-31 | $10.33M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $13.62M derived: sum of 2 quarters · filed 2018-02-23 | $13.91M derived: sum of 3 quarters · filed 2018-02-23 | $14.97M 10-K · filed 2018-02-23 | |
| 2016-09-30 | $3.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $3.58M derived: sum of 2 quarters · filed 2017-11-07 | $4.64M 10-Q · filed 2017-11-07 | $3.98M derived: sum of 4 quarters · filed 2017-11-07 | |
| 2016-06-30 | $285.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $1.35M 10-Q · filed 2017-08-01 | $681.00K derived: sum of 3 quarters · filed 2017-08-01 | $2.26M derived: sum of 4 quarters · filed 2017-08-01 | |
| 2016-03-31 | $1.06M 10-Q · filed 2017-05-02 | $396.00K derived: sum of 2 quarters · filed 2017-05-02 | $1.97M derived: sum of 3 quarters · filed 2017-05-02 | $1.14M derived: sum of 4 quarters · filed 2017-05-02 | |
| 2015-12-31 | -$666.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $910.00K derived: sum of 2 quarters · filed 2017-02-24 | $78.00K derived: sum of 3 quarters · filed 2017-02-24 | $1.29M 10-K · filed 2017-02-24 | |
| 2015-09-30 | $1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $744.00K derived: sum of 2 quarters · filed 2016-11-02 | $1.96M 10-Q · filed 2016-11-02 | $1.61M 10-Q · filed 2015-11-05 | $1.90M derived: sum of 4 quarters · filed 2016-11-02 |
| 2015-06-30 | -$832.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $385.00K 10-Q · filed 2016-08-08 | $326.00K derived: sum of 3 quarters · filed 2016-08-08 | $370.00K derived: sum of 4 quarters · filed 2016-08-08 | |
| 2015-03-31 | $1.22M 10-Q · filed 2016-05-04 | $1.16M derived: sum of 2 quarters · filed 2016-05-04 | $1.20M derived: sum of 3 quarters · filed 2016-05-04 | ||
| 2014-12-31 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$15.00K derived: sum of 2 quarters · filed 2016-02-26 | $1.26M 10-K · filed 2016-02-26 | ||
| 2014-09-30 | $44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $1.32M 10-Q · filed 2015-11-05 | |||
| 2014-06-30 | $1.28M 10-Q · filed 2015-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |